COMPOSITION FOR PREVENTING OR TREATING FATTY LIVER DISEASES
    5.
    发明公开
    COMPOSITION FOR PREVENTING OR TREATING FATTY LIVER DISEASES 审中-公开
    ZUSAMMENSETZUNG ZUR PREVENTION ODER BEHANDLUNG VON FETTLEBERERKRANKUNGEN

    公开(公告)号:EP3132795A1

    公开(公告)日:2017-02-22

    申请号:EP15779540.2

    申请日:2015-04-17

    摘要: The present invention relates to a pharmaceutical composition for preventing or treating fatty liver diseases, containing (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine or a pharmaceutically acceptable salt thereof as active ingredients. (Tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine or a pharmaceutically acceptable salt thereof, according to the present invention, can effectively inhibit fatty liver, hepatitis and hepatic fibrosis and can be useful for preventing or treating NAFLD, and in particular, NASH.

    摘要翻译: 本发明涉及含有(四氢吡喃-4-基) - [2-苯基-5-(1,1-二氧代硫代吗啉-4-基)甲基-1H-吲哚的脂肪肝疾病的预防或治疗药物组合物 -7-基]胺或其药学上可接受的盐作为活性成分。 (四氢吡喃-4-基) - [2-苯基-5-(1,1-二氧代 - 硫代吗啉-4-基)甲基-1H-吲哚-7-基]胺或其药学上可接受的盐,根据本发明 本发明能有效抑制脂肪肝,肝炎,肝纤维化,可用于预防或治疗NAFLD,特别是NASH。

    INDOLE AMIDE COMPOUND AS INHIBITOR OF NECROSIS
    10.
    发明公开
    INDOLE AMIDE COMPOUND AS INHIBITOR OF NECROSIS 审中-公开
    吲哚酰胺化合物作为坏死物质的抑制剂

    公开(公告)号:EP3037412A1

    公开(公告)日:2016-06-29

    申请号:EP14838146.0

    申请日:2014-08-21

    摘要: The present invention relates to an indole amide compound represented by formula (1), a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.

    摘要翻译: 本发明涉及由式(1)表示的吲哚酰胺化合物,其药学上可接受的盐或异构体,用于预防或治疗坏死和坏死相关疾病的组合物,以及用于制备该组合物的方法,该组合物包含 吲哚化合物或其药学上可接受的盐或异构体作为活性成分。